Cite
APA Citation
Gumus, M., Sukalinskaya, A., Andric, Z., Cheshuk, V., Ciuleanu, T., Sezgin Goksu, S., Cil, T., Cicin, I., Bulat, I., Ostapenko, Y., Penkov, K., Hart, C., Lai, M., Chaao, B., Jimenez, J., Sepahi, A., Shi, G., Trott, S., & Hooper, E. (n.d.). 181P SELECT: A phase II randomized trial evaluating 2 doses of vopratelimab (V) + pimivalimab (P) vs P in TISvopra selected patients (pts). Immuno-oncology technology, 16, . http://access.bl.uk/ark:/81055/vdc_100172068928.0x000008